NOVEL ANTI-LILRB4 ANTIBODIES AND USES THEREOF

The present disclosure provides anti-LILRB4 antibodies or antigen-binding fragments thereof, pharmaceutical composition comprising the same and the uses thereof. La présente invention concerne des anticorps anti-LILRB4 ou des fragments de liaison à l'antigène de ceux-ci, une composition pharmac...

Full description

Saved in:
Bibliographic Details
Main Authors GAO, Mengshi, BAI, Suya, MEI, Jay, HOU, Bing, SUN, Ao, SHAN, Bo, YUWEN, Hui, ZHENG, Enlin, CHEN, Peng
Format Patent
LanguageEnglish
French
Published 14.12.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides anti-LILRB4 antibodies or antigen-binding fragments thereof, pharmaceutical composition comprising the same and the uses thereof. La présente invention concerne des anticorps anti-LILRB4 ou des fragments de liaison à l'antigène de ceux-ci, une composition pharmaceutique les comprenant et leurs utilisations.
Bibliography:Application Number: WO2023CN98246